Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Country / region: Philippines Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20101
20111
20121
20131
20181
20191
20202
20213
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Terminated4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Human Genome Sciences Inc., a GSK Company3
Viatris Innovation GmbH3
Biogen2
UCB Biopharma SRL2
Anthera Pharmaceuticals1
AstraZeneca1
Human Genome Sciences Inc.1
La Jolla Pharmaceutical Company1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic19
Autoimmune Diseases9
Connective Tissue Diseases5
Immune System Diseases5
Lupus Nephritis3
Nephritis2
Glomerulonephritis1
Kidney Diseases1
Skin and Connective Tissue Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.